Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients

J Interferon Res. 1994 Aug;14(4):211-3. doi: 10.1089/jir.1994.14.211.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antibody Specificity
  • Antigen-Antibody Reactions*
  • Chronic Disease
  • Hepatitis C / drug therapy*
  • Hepatitis C / immunology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / immunology
  • Interferon-alpha / therapeutic use*
  • Recombinant Proteins
  • Retrospective Studies

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins